Portal de recerca
Early feeding practices in infants with phenylketonuria across Europe
Data de publicació:
Autors de IIS La Fe
Autors aliens a IIS La Fe
- Pinto, A
- Adams, S
- Ahring, K
- Allen, H
- Almeida, MF
- Garcia-Arenas, D
- Arslan, N
- Assoun, M
- Altinok, YA
- Barrio-Carreras, D
- Quintana, AB
- Bernabei, SM
- Bontemps, C
- Boyle, F
- Bruni, G
- Bueno-Delgado, M
- Caine, G
- Carvalho, R
- Chrobot, A
- Chyz, K
- Cochrane, B
- Correia, C
- Corthouts, K
- Daly, A
- De Leo, S
- Desloovere, A
- De Meyer, A
- De Theux, A
- Didycz, B
- Dijsselhof, ME
- Dokoupil, K
- Drabik, J
- Dunlop, C
- Eberle-Pelloth, W
- Eftring, K
- Ekengren, J
- Errekalde, I
- Evans, S
- Foucart, A
- Fokkema, L
- Francois, L
- French, M
- Forssell, E
- Gingell, C
- Goncalves, C
- Ozel, HG
- Grimsley, A
- Gugelmo, G
- Gyure, E
- Heller, C
- Hensler, R
- Jardim, I
- Joost, C
- Jorg-Streller, M
- Jouault, C
- Jung, A
- Kanthe, M
- Koc, N
- Kok, IL
- Kozanoglu, T
- Kumru, B
- Lang, F
- Lang, K
- Liegeois, I
- Lilje, R
- Lubina, O
- Manta-Vogli, P
- Mayr, D
- Meneses, C
- Newby, C
- Meyer, U
- Mexia, S
- Nicol, C
- Och, U
- Olivas, SM
- Pedron-Giner, C
- Pereira, R
- Plutowska-Hoffmann, K
- Purves, J
- Dionigi, AR
- Reinson, K
- Robert, M
- Robertson, L
- Rocha, JC
- Rohde, C
- Rosenbaum-Fabian, S
- Rossi, A
- Ruiz, M
- Saligova, J
- Gutierrez-Sanchez, A
- Schlune, A
- Schulpis, K
- Serrano-Nieto, J
- Skarpalezou, A
- Skeath, R
- Slabbert, A
- Straczek, K
- Gizewska, M
- Terry, A
- Thom, R
- Tooke, A
- Tuokkola, J
- van Dam, E
- van den Hurk, TAM
- van der Ploeg, EMC
- Vande Kerckhove, K
- Van Driessche, M
- van Wegberg, AMJ
- van Wyk, K
- Vasconcelos, C
- Wildgoose, J
- Winkler, T
- Zolkowska, J
- Zuvadelli, J
- MacDonald, A
Grups d'Investigació
Abstract
Background: In infants with phenylketonuria (PKU), dietary management is based on lowering and titrating phenylalanine (Phe) intake from breast milk or standard infant formula in combination with a Phe-free infant formula in order to maintain blood Phe levels within target range. Professionals use different methods to feed infants with PKU and our survey aimed to document practices across Europe. Methods: We sent a cross sectional, survey monkey (R) questionnaire to European health professionals working in IMD. It contained 31 open and multiple-choice questions. The results were analysed according to different geographical regions. Results: Ninety-five centres from 21 countries responded. Over 60% of centres commenced diet in infants by age 10 days, with 58% of centres implementing newborn screening by day 3 post birth. At diagnosis, infant hospital admission occurred in 61% of metabolic centres, mainly in Eastern, Western and Southern Europe. Breastfeeding fell sharply following diagnosis with only 30% of women still breast feeding at 6 months. 53% of centres gave pre-measured Phe-free infant formula before each breast feed and 23% alternated breast feeds with Phe-free infant formula. With standard infant formula feeds, measured amounts were followed by Phe-free infant formula to satiety in 37% of centres (n = 35/95), whereas 44% (n = 42/95) advised mixing both formulas together. Weaning commenced between 17 and 26 weeks in 85% centres, >= 26 weeks in 12% and < 17 weeks in 3%. Discussion: This is the largest European survey completed on PKU infant feeding practices. It is evident that practices varied widely across Europe, and the practicalities of infant feeding in PKU received little focus in the PKU European Guidelines (2017). There are few reports comparing different feeding techniques with blood Phe control, Phe fluctuations and growth. Controlled prospective studies are necessary to assess how different infant feeding practices may influence longer term feeding development.
Dades de la publicació
- ISSN/ISSNe:
- 2214-4269, 2214-4269
- Tipus:
- Article
- Pàgines:
- 82-89
- PubMed:
- 30101073
- Factor d'Impacte:
- 0,595 SCImago ℠
- Quartil:
- Q3 SCImago ℠
Molecular Genetics And Metabolism Reports ELSEVIER SCIENCE BV
Cites Rebudes en Web of Science: 14
Documents
- No hi ha documents
Filiacions
Keywords
- Breastfeeding; Infant practices; Phenylketonuria; Phenylalanine; Phe-free infant formula
Projectes associats
SPLICING Y EPIGENÉTICA EN SMD. Uso de modelos crispr/cas9 para estudiar el impacto de mutaciones genéticas y epigenéticas co-ocurrentes en los síndromes mielodisplásicos.
Investigador Principal: ALEJANDRA SANJUAN PLA
SAF2017-82171-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2018
ESTUDIO POSTAUTORIZACIÓN DE SEGURIDAD (EPAS) NO INTERVENCIONAL PARA EVALUAR LA SEGURIDAD A LARGO PLAZO DEL TRATAMIENTO CON ORFADIN EN LA TIROSINEMIA HEREDITARIA TIPO 1 (TH-1) EN LA PRÁCTICA CLÍNICA ESTÁNDAR.
Investigador Principal: ISIDRO VITORIA MIÑANA
SWE-NIT-2013-01 . 2014
ESTUDIO OBSERVACIONAL, AMBISPECTIVO DE HISTORIA NATURAL EN PACIENTES CON MUCOPOLISACARIDOSIS TIPO IIIA (MPS IIIA) O SÍNDROME DE SANFILIPPO TIPO A.
Investigador Principal: ISIDRO VITORIA MIÑANA
EST-SFA-2013-01 . 2014
OPTIMIZACIÓN DE LAS TERAPIAS DE SUSTITUCIÓN ENZIMÁTICA EN PACIENTES CON ENFERMEDADES DE DEPÓSITO LISOSOMAL.
Investigador Principal: JOSÉ LUIS POVEDA ANDRÉS
JLP-ELO-2017-01
SUBREGISTRO PROSPECTIVO, MULTICÉNTRICO Y OBSERVACIONAL DE SEGURIDAD POSTAUTORIZACIÓN PARA CARACTERIZAR EL PERFIL DE SEGURIDAD A LARGO PLAZO DEL USO COMERCIAL DE ELIGLUSTAT (CERDELGA®) EN PACIENTES ADULTOS CON ENFERMEDAD DE GAUCHER.
Investigador Principal: PATRICIA CORRECHER MEDINA
OBS14099 . 2018
ESTUDIO DE RESULTADOS DE HUNTER: REGISTRO OBSERVACIONAL, INTERNACIONAL Y MULTICÉNTRICO A LARGO PLAZO DE PACIENTES CON SÍNDROME DE HUNTER (MUCOPOLISACARIDOSIS DE TIPO II, MPS II).
Investigador Principal: ISIDRO VITORIA MIÑANA
SHI-IDU-2011-01 . 2014
PROTOCOLO DEL REGISTRO DE LA ENFERMEDAD DE GAUCHER.
Investigador Principal: ISIDRO VITORIA MIÑANA
GEN-GAU-2013-01 . 2018
PROTOCOLO DE VIGILANCIA DEL E-HOD/CYSTADANE.
Investigador Principal: JAIME DALMAU SERRA
ORP-CYS-2014-01
MONITORIZACIÓN E INDIVIDUALIZACIÓN POSOLÓGICA DE GLUCOCEREBROSIDASA EN PACIENTES GAUCHER TIPO I.
Investigador Principal: ISIDRO VITORIA MIÑANA
FIS-IMI-2012-01